Metabolic function and weight loss after endoscopic sleeve gastroplasty: resistance is futile

Autor: Andrew C. Storm, Barham K. Abu Dayyeh
Rok vydání: 2021
Předmět:
Zdroj: Gastrointestinal Endoscopy
ISSN: 0016-5107
DOI: 10.1016/j.gie.2020.11.022
Popis: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the United States and is closely associated with obesity and insulin resistance (IR). Weight loss is the best treatment for NAFLD. Endoscopic sleeve gastroplasty (ESG) is a promising endoscopic procedure for treatment of obesity. Our aim is to evaluate the change in IR and estimated hepatic steatosis and fibrosis after ESG.One hundred eighteen patients with obesity and NAFLD underwent ESG and were followed for 2 years. Weight loss was evaluated as % total body weight loss. IR was evaluated using the homeostasis model assessment of insulin resistance (HOMA-IR). The previously validated hepatic steatosis index and NAFLD fibrosis score were used to estimate hepatic steatosis and risk of fibrosis.Patients' mean body mass index was 40 ± 7 kg/mOur results suggest a significant and sustained improvement in estimated hepatic steatosis and fibrosis after ESG in patients with NAFLD. Importantly, we showed an early and weight-independent improvement in insulin resistance, which lasted for 2 years after the procedure.
Databáze: OpenAIRE